Related Articles
A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA
The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil
Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells
5FU resistance caused by reduced fluoro‑deoxyuridine monophosphate and its reversal using deoxyuridine
Cinnamaldehyde/chemotherapeutic agents interaction and drug-metabolizing genes in colorectal cancer